(Reuters) - Cardinal, one of the top three U.S. drug distributors, said more than 80 percent of the outstanding shares of Viasys have been tendered. The Dublin, Ohio-based company said in May it would pay about $1.42 billion to acquire Viasys, which makes medical products for respiratory care and other uses.
Cardinal said it expects to acquire the remaining shares and complete the acquisition by June 30.
Read more at Reuters.com Bonds News
Cardinal said it expects to acquire the remaining shares and complete the acquisition by June 30.
Read more at Reuters.com Bonds News
No comments:
Post a Comment